Clin2
NCT07552883Worth exploringNot yet recruiting

Removing throat coating after repeat radiation for nasopharyngeal cancer

Nasopharyngeal Carcinoma (NPC)Radiation InjuriesNecrosis

Part of Cancer, Ear, nose & throat, Injuries & trauma, Mouth & dental clinical trials.

This trial studies a procedure to remove a thick, white coating (called a pseudomembrane) that can form in the nose and throat after a second round of radiation therapy for nasopharyngeal cancer. The goal is to see if removing this coating improves healing and symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • Be between 18 and 80 years old.
  • Have previously received radiation therapy for nasopharyngeal cancer, with a total dose of at least 66 Gy.
  • Have been told by a doctor that your cancer has recurred (come back) in the nasopharynx or nearby lymph nodes.
  • Are currently receiving or have completed a second course of radiation therapy with a total dose of at least 50 Gy.
  • Have developed a pseudomembrane (a thick, white coating) on the lining of the nose or throat during or after your second radiation.
  • Be well enough to undergo an endoscopic procedure (a thin, flexible tube with a camera inserted through the nose).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07789158Not yet recruiting· Phase 2
Lower radiation dose for early-stage nasopharyngeal cancer

This trial tests whether people with early-stage nasopharyngeal cancer can receive a lower dose of radiation after chemotherapy, which may reduce side effects while still treating the cancer effectively.

Shanghai, Shanghai Municipality
NCT07277764Recruiting· Phase 2
Radiation and immunotherapy for returning nasopharyngeal cancer

This trial tests a combination of high and low dose radiation plus an immunotherapy drug (PD-1 inhibitor) for people whose nasopharyngeal cancer has come back after previous treatment. The goal is to see if this approach can be more effective while reducing side effects.

Nanchang, Jiangxi
NCT07072000Not yet recruiting· Phase 3
Reducing radiation to the nasal cavity for nasopharyngeal cancer

This trial tests whether shrinking the area that gets radiation in the nasal cavity can reduce side effects while still treating the cancer effectively. If you have nasopharyngeal cancer that has spread into your nose, this study might help lower radiation exposure to that area.

Foshan, Guangdong
NCT06533267Recruiting
Endoscopic surgery vs. radiation for early-stage nasal cancer

This trial compares two treatments for stage I nasopharyngeal cancer (a type of nasal cancer). It tests whether a minimally invasive surgery (endoscopic surgery) is as good as or better than radiation therapy. It may be an option for people whose cancer is small and hasn't spread to lymph nodes.

Zhuhai, Guangdong
NCT07692906Not yet recruiting
Guided surveillance and less invasive neck surgery for advanced nasopharyngeal cancer

This trial tests a new way of managing advanced nasopharyngeal cancer that has spread to the neck after radiation therapy. It uses regular imaging and exams to guide a less invasive neck surgery, aiming to remove any remaining cancer while preserving healthy tissue.

NCT04215510Not yet recruiting· Phase 3
Surgery or radiation for recurrent nasopharyngeal cancer

This trial compares two treatments for early-stage nasopharyngeal cancer that has returned after radiation: surgery versus intensity-modulated radiation therapy (IMRT). The goal is to see which approach is more effective at controlling the cancer while keeping side effects manageable.

Fuzhou, Fujian

Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.